Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications primarily in the United States and Canada. The company?s fluid delivery products comprise luer syringe check valves and one-way valves; tubing clamps; and specialized intravenous sets for use in anesthesia and oncology applications. Its cardiovascular products include MPS2 Myocardial Protection System that delivers essential fluids and medications to the heart during open-heart surgery; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The company?s ophthalmic products comprise contact lens disinfection cases; and a line of ballo
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||16.48||EPS Growth - 4 Quarters||10.05%||EPS Growth - Q/Q||35.26%|
|EPS Growth - Y/Y||2.83%||Sales Growth - 4 Quarters||9.42%||Sales Growth - Q/Q||17.22%||P/E||34.28|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||17.74%||ROE||20.25%||ROI|
|Current Ratio||9.73||Quick Ratio||5.97||Long Term Debt/Equity||Debt Ratio||0.05|
|Gross Margin||48.82%||Operating Margin||29.16%||Net Profit Margin||19.77%||Dividend Payout Ratio||-19.75%|
|Cash From Financing Activities||-18.39 M||Cash From Investing Activities||5.74 M||Cash From Operating Activities||7.75 M||Gross Profit||18.52 M|
|Net Profit||7.6 M||Operating Profit||11.49 M||Total Assets||158.99 M||Total Current Assets||69.19 M|
|Total Current Liabilities||7.11 M||Total Debt||Total Liabilities||19.69 M||Total Revenue||38.32 M|
|High 52 week||806.44||Low 52 week||525.75||Last close||806.44||Last change||1.13%|
|RSI||72.05||Average true range||12.98||Beta||0.58||Volume||8.48 K|
|Simple moving average 20 days||2.91%||Simple moving average 50 days||6.91%||Simple moving average 200 days||19.09%|
|Performance Week||1.61%||Performance Month||3.08%||Performance Quart||11.6%||Performance Half||25.63%|
|Performance Year||38.63%||Performance Year-to-date||9%||Volatility daily||1.04%||Volatility weekly||2.32%|
|Volatility monthly||4.75%||Volatility yearly||16.47%||Relative Volume||216.8%||Average Volume||9.83 K|
|New High||New Low|
2019-03-04 12:22:09 | Is Atrion Corporation’s NASDAQ:ATRI Balance Sheet A Threat To Its Future?
2019-02-26 16:30:00 | Atrion Reports Results for Fourth Quarter and Full Year 2018
2019-02-26 14:17:24 | Atrion Corporation Declares Quarterly Cash Dividend
2019-02-21 08:00:00 | Investor Expectations to Drive Momentum within International Business Machines, Trex, ForeScout Technologies, Red Hat, Amedisys, and Atrion — Discovering Underlying Factors of Influence
2019-02-06 11:20:11 | Have Insiders Been Selling Atrion Corporation NASDAQ:ATRI Shares?
2019-01-11 10:47:40 | Should You Like Atrion Corporation’s NASDAQ:ATRI High Return On Capital Employed?
2018-12-10 12:37:32 | Does Atrion Corporation’s NASDAQ:ATRI CEO Pay Compare Well With Peers?
2018-11-12 13:22:31 | Atrion Corporation Declares Quarterly Cash Dividend
2018-11-09 16:34:28 | Atrion: 3Q Earnings Snapshot
2018-11-09 16:30:00 | Atrion Reports Third Quarter Results
2018-11-09 13:30:47 | Do Insiders Own Lots Of Shares In Atrion Corporation NASDAQ:ATRI?
2018-10-19 08:20:00 | Research Report Identifies Loxo Oncology, Atrion, Alexander's, Broadridge Financial Solutions, International Flavors & Fragrances, and Conagra Brands with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
2018-10-10 14:27:20 | Does Atrion Corporation’s NASDAQ:ATRI PE Ratio Warrant A Buy?
2018-09-04 14:16:43 | Can Atrion Corporation’s NASDAQ:ATRI ROE Continue To Surpass The Industry Average?
2018-08-14 16:30:00 | Atrion Corporation Increases Quarterly Cash Dividend by 13%
2018-08-07 17:00:50 | Atrion: 2Q Earnings Snapshot
2018-08-07 16:45:00 | Atrion Reports Second Quarter Results
2018-05-24 08:25:00 | New Research: Key Drivers of Growth for CSW Industrials, Cavco Industries, Intra-Cellular Therapies, Atrion, QAD, and A V Homes — Factors of Influence, Major Initiatives and Sustained Production
2018-05-22 15:05:12 | Atrion Corporation Declares Quarterly Cash Dividend
2018-05-10 05:12:13 | Atrion: 1Q Earnings Snapshot
2018-05-09 16:30:00 | Atrion Reports First Quarter Results
2018-04-03 08:00:00 | Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals — Discovering Underlying Factors of Influence
2018-03-12 08:00:00 | Free Post Earnings Research Report: Mettler-Toledo’s Quarterly Earnings Increased 13.07%
2018-03-10 09:14:26 | Atrion Corporation NASDAQ:ATRI Delivered A Better ROE Than The Industry, Here’s Why
2018-02-28 05:03:10 | Atrion posts 4Q profit
2018-02-27 16:30:00 | Atrion Reports 2017 Results for Fourth Quarter and Full Year
2018-02-27 14:31:37 | Atrion Corporation Declares Quarterly Cash Dividend
2018-02-21 11:58:22 | Should You Be Tempted To Buy Atrion Corporation NASDAQ:ATRI Because Of Its PE Ratio?
2017-12-18 14:38:32 | ETFs with exposure to Atrion Corp. : December 18, 2017
2017-12-05 08:36:37 | Atrion Corp. :ATRI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017
2017-12-01 10:26:09 | ETFs with exposure to Atrion Corp. : December 1, 2017
2017-11-26 06:05:05 | Does Atrion Corporation’s ATRI 18.4% Earnings Growth Make It An Outperformer?
2017-11-08 18:51:51 | Atrion posts 3Q profit
2017-11-08 16:30:00 | Atrion Reports Third Quarter Results
2017-11-08 12:41:17 | Atrion Corporation Declares Quarterly Cash Dividend
2017-11-07 09:41:30 | ETFs with exposure to Atrion Corp. : November 7, 2017
2017-11-01 11:05:15 | Should You Be Tempted To Buy Atrion Corporation ATRI At Its Current Price?
2017-10-26 11:01:43 | Atrion Corp. – Value Analysis NASDAQ:ATRI : October 26, 2017
2017-10-02 10:41:24 | ETFs with exposure to Atrion Corp. : October 2, 2017
2017-09-13 17:22:29 | ETFs with exposure to Atrion Corp. : September 13, 2017
2017-09-08 17:01:50 | Atrion Corp. :ATRI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017
2017-08-28 20:01:45 | Atrion Corp. – Value Analysis NASDAQ:ATRI : August 29, 2017